e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Which treatment other than chemotherapy for stage IV NSCLC?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Advances in the radiotherapy of brain metastases
D. Antoni (Strasbourg, France)
Source:
Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
Session:
Which treatment other than chemotherapy for stage IV NSCLC?
Session type:
Symposium
Number:
1464
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Antoni (Strasbourg, France). Advances in the radiotherapy of brain metastases. Annual Congress 2013 –Which treatment other than chemotherapy for stage IV NSCLC?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Lung function assessment in octogenarians with lung cancer diagnosis
Home-based telerehabilitation program using real-time monitoring and interactive exercise for patient with lung cancer: A feasibility study
Related content which might interest you:
Multimodal management of brain metastases in lung cancer
Source: International Congress 2018 – State of the art session: Thoracic oncology
Year: 2018
Whole brain re-irradiation in lung cancer patients with multiple brain metastases
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
Whole brain radiotherapy for brain – only metastases of small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 755s
Year: 2006
Is there a role for radiotherapy in mediastinal tumours?
Source: Annual Congress 2013 –Mediastinal tumours excluding thymoma
Year: 2013
Palliative radiotherapy for brain- only metastases of non small cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008
Treatment modalities in lung cancer patients with brain metastasis
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
The estimations of two regimenes of radiation of brain metastases in patients with primary lung cancer
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007
Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC
Source: Eur Respir J 2012; 39: 1039-1042
Year: 2012
Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
Brain metastases in lung cancer patients
Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients.
Year: 2019
Temozolomide in the treatment of brain metastases in lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 65s
Year: 2003
Contribution of FDG-PET on staging and management of NSCLC planned for concomitant chemoradiotherapy
Source: Eur Respir J 2007; 30: Suppl. 51, 664s
Year: 2007
Cryotherapy as an adjuvant to radiotherapy in lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 76s
Year: 2005
Multimodality lung cancer therapy – nonsurgical complications
Source: Annual Congress 2008 - High-risk patients for major lung cancer surgery
Year: 2008
Toxicity in isolated lung perfusion with melphalan for resectable lung metastases
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006
Current challenges in the management of nonsmall cell lung cancer brain metastases
Source: Eur Respir J, 55 (1) 1901686; 10.1183/13993003.01686-2019
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept